Affiliation:
1. Dermatology Unit, Department of Medicine , Nnamdi Azikiwe University Teaching Hospital , Nnewi , Anambra State Nigeria .
2. Dermatology Unit, Department of Internal Medicine , Ladoke Akintola University of Technology , Ogbomoso and LAUTECH Teaching Hospital , Ogbomoso , Oyo State, Nigeria
3. Dermatology Unit, Department of Medicine , Nnamdi Azikiwe University Nnewi Campus , Anambra State Nigeria .
4. University of Benin and University of Benin Teaching Hospital , Edo State, Nigeria
Abstract
Abstract
Introduction. Lichen planus is a chronic inflammatory skin disease known to have several clinical variants with attended variable clinical outcomes. Certain complications have been observed in the hypertrophic type, which were not found in association with the classic variant.
Objective: To identify the epidemiologic and clinical differences between the classic and hypertrophic lichen planus and clinical correlates.
Material and Methods. Of 104 participants with lichen planus included in the study, 49 had classic and 55 hypertrophic lichen planus. Demographic and clinical information was obtained. Diagnosis of lichen planus was made clinically and confirmed with histology. The participants were screened for metabolic syndrome, hepatitis B, and C.
Results: Mean age of all patients was 37.20±13.39 years, with no age and gender differences between the participants with classic and hypertrophic lichen planus. Classic lichen planus was more likely to be painful, (8.2% vs 0.0, p=0.046), generalized (95.9% vs 16.4%, p<0.001), involve the oral mucosa (38.8% vs 0.0, p<0.001), the nails (38.8% vs 1.8, p<0.001), present with kobnerisation (55.1% vs 5.5%,<0.001), Wickhiam striae (69.4% vs 16.4%, p<0.001), associated with Hepatitis B vaccination (16.3% vs 3.6%, p<0.028) and anti HCV positivity (16.3% vs 0.0%, p=0.002). Hypertrophic lichen planus was significantly associated with impaired glucose tolerance/diabetes mellitus (16.4% vs 2.0%, p=0.013), dyslipidemia (74.5% vs 40.8%, p=0.001) and saw-tooth histologic appearance compared to classic type.
Conclusion: Hypertrophic lichen planus is more likely to be associated with metabolic complications compared to the classic type. Further studies are needed to loink this difference t chronic inflamation.
Reference39 articles.
1. 1. Black MM. Lichen planus and lichenoid disorders. In: Champion RH, Burton JL, Ebling FJG, Rook AJ, Wilkinson DS. Textbook of dermatology. Vol. 3. 5th ed. Oxford: Blackwell Scientific Publications; 1992. p. 1675.
2. 2. Boyd AS, Neldner KH. Lichen planus. J Am Acad Dermatol. 1991;25(4):593-619.10.1016/0190-9622(91)70241-S1791218
3. 3. Usatine RP, Tinitigan M. Diagnosis and treatment of lichen planus. Am Fam Physician. 2011:84(1):53-60.
4. 4. Katta R. Lichen planus. Am Fam Physician. 2000;62(8): 1786. Erratum for: Am Fam Physician. 2000;61(11):3319-24.
5. 5. Weston G, Payette M. Update on lichen planus and its clinical variants. Int J Womens Dermatol. 2015;1(3):140-9.10.1016/j.ijwd.2015.04.001